TP53 and cancer: In fact, cancer cells are generally more sensitive to CPT than normal cells, because cells mutated in either ARF or p53 accumulate H2AX in response to CPT-induced damage, which results in increased γH2AX foci formation, a heightened damage response, and efficient induction of cell death [7].